Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-25 @ 4:02 AM
NCT ID:
NCT02837302
Eligibility Criteria:
Inclusion Criteria:
* Advanced liver cirrhosis patients with Child-Pugh score 8 to 10
Exclusion Criteria:
* Diagnosis of malignancy (except hepatocellular carcinoma) within 3 years or untreated malignancy
* Major organ failure (heart, lung and kidney) need to admission or medical therapy or dialysis
* Patients already on a waiting list or being considered for major organ transplantation.
* Serum creatinine above upper normal range (\>1.5 mg/dL)
* Patients treating with albumin replacement regularly
* Viable hepatocellular carcinoma or advanced Barcelona Clinic Liver Cancer stage or hepatocellular carcinoma below 6 months life expectancy
* Patients being impossible to secession of alcohol consumption
* Patients being impossible to oral ingestion or oral medication
* Pregnancy or being considered for pregnancy
* Breast feeding
* Amyotrophic lateral sclerosis
* Patients with other metabolic disorder presenting branched-chain ketoaciduria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02837302
Study Brief:
Protocol Section:
NCT02837302